The Burgess Group Selects Concert Genetics to Power Genetic Test Claims Payment Automation
The Burgess Group Selects Concert Genetics to Power Genetic Test Claims Payment Automation News provided by Share this article Share this article ALEXANDRIA, Va. and NASHVILLE, Tenn., Dec. 15, 2020 /PRNewswire/ -- The Burgess Group ("Burgess"), a HealthEdge company, an innovative payment integrity software company focused on improving healthcare payment operations through technology, has selected Concert Genetics to deliver genetic testing claim edits within the Burgess Source® claims payment automation and business intelligence platform. The solution integrates Concert's real-time claim edi...
Source: prnewswire.com